In one of the first complaints filed related to the Genetic Insurance Nondiscrimination Act, a Connecticut woman has filed complaints with the U.S. Equal Opportunity Commission and the Connecticut Commission on Human Rights and Opportunities. According to the Boston Herald, Pamela Fink, 39, of Fairfield, Connecticut, alleges that her employer, MXenergy fired her after she disclosed to them that she had a mutation in the BRCA2 gene (which confers hereditary breast and ovarian cancer susceptibility).
Woman Files Complaint Claiming She Was Fired Over Positive BRCA2 Test for Hereditary Breast and Ovarian Cancer
Filed Under: BRCA1, BRCA2, Breast Cancer, Cancer Genetics, Cancer Prevention, ELSI (Ethical, Legal, and Social Issues), GINA, Hereditary Breast and Ovarian Cancer, Ovarian Cancer, Prophylactic Mastectomy Tagged: bilateral mastectomy, BRCA2, breast cancer, double mastectomy, firing, genetic discrimination, Genetic Insurance Nondiscrimination Act, genetic test, GINA, ovarian cancer, prophylactic mastectomy